Trial intelligence / Profile preview

Antenatal betamethasone for prevention of respiratory distress syndrome in late preterm infants undergoing elective cesarean section

2011-002919-28Phase 3Terminated

Sponsor: Policlinico di Milano
Start: Dec 2011
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries: 1

Overview

Phase 3, randomised trial of betamethasone in respiratory distress syndrome (RDS) (2 arms), sponsored by Policlinico di Milano. Primary endpoint: Incidence of respiratory distress syndrome requiring ventilatory support within first 72 hours of life. Started Dec 2011; status: terminated.

Drugs

betamethasone

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on 2011-002919-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002919-28.